PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663530
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663530
Capsule Endoscopy Market size was valued at US$ 551.6 Million in 2024, expanding at a CAGR of 9.80% from 2025 to 2032.
A minimally invasive method for inspecting the inside of the digestive tract, especially the small intestine, is capsule endoscopy. A tiny pill-sized capsule with a transmitter, light source, and camera is swallowed by the patient. The capsule records pictures as it passes through the digestive tract and transmits them to a patient-worn external device. This method aids in the diagnosis of malignancies, Crohn's disease, celiac disease, and gastrointestinal bleeding. One of the main factors propelling the market's expansion is the rising incidence of colorectal cancer and gastrointestinal illnesses worldwide. Furthermore, the market is expanding as a result of growing public knowledge of the availability of painless and MI visualization methods for the treatment of such conditions. For prompt diagnosis and better patient care, oesophagal, small bowel, and colon capsule endoscopes are widely utilized in hospitals and other healthcare facilities. Accordingly, the market is expanding due to the growing geriatric population, which is more prone to conditions including appendicitis, inflammatory bowel disease, and Obscure Gastrointestinal Bleeding (OGIB).
Capsule Endoscopy Market- Market Dynamics
Growing advancements in endoscopic treatment technology
The range of uses for capsule endoscopy systems has increased due to technological developments and now includes conditions of the colon, small intestine, and oesophagus. Advances in technology have enhanced the diagnostic, monitoring, and viewing capabilities of traditional endoscopy. New kinds of capsule endoscopes, including those for the oesophagus, colon, and small intestine, have been developed as a result of advanced technology. Product manufacturers are also producing cameras with 360-degree panoramic vision that are easy to use and have great resolution. It would have been difficult to attain a high level of accuracy, safety, and precision only a few years ago, but advancements in endoscopy have made it possible. The video scope and the capsule endoscope have recently replaced the fiberoptic endoscope (fiberscope). Additionally, the PillCam Small Bowel 3 system for remote endoscopic treatments was released in November 2021. The PillCam SB3 @HOME initiative uses Medtronic's PillCam technology with Amazon logistics to provide patients with quick, dependable results from the comfort of their own homes. The PillCam SB3 @HOME telehealth feature enables direct small bowel vision and monitoring. It can help detect lesions that upper and lower endoscopy misses and could disclose the causes of iron deficiency anaemia (IDA), uncover concealed bleeding, or suggest Crohn's disease.
Capsule Endoscopy Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.80% over the forecast period (2025-2032)
Based on application segmentation, the OGIB (Obscure GI Tract Bleeding) was predicted to show maximum market share in the year 2024
Based on end use segmentation, hospitals were the leading segment in 2024
On the basis of region, North America was the leading revenue generator in 2024
The Global Capsule Endoscopy Market is segmented on the basis of Application, Product, End Use, and Region.
On the basis of application, the market is segregated into Small Intestine Tumor, OGIB (Obscure GI Tract Bleeding), Crohn's Disease, and Others. In 2024, the market was dominated by the OGIB (Obscure GI Tract Bleeding) category because of the many benefits that capsule endoscopy offers in terms of OGIB diagnosis and detection. The use of capsule endoscopes for OGIB is also growing due to advantages such as real-time imaging, picture capture, examination of the entire small intestine, and accurate and dependable results. The market's expansion is also being aided by the tendency toward the use of capsule-based endoscopy screening for OGIB rather than more traditional techniques like double-balloon enteroscopy. Throughout the forecast period, the Crohn's disease segment is expected to grow at a significant rate.
Based on end use, the market is divided into Hospitals, Clinics, Ambulatory Surgery Centers, and Others. In 2024, the hospitals category held a dominant market share. It is associated with hospitals' far greater use, uptake, and utilization of capsule endoscopy services in comparison to other healthcare systems. The government's liberal reimbursement regulations are also aiding the market growth for capsule endoscopies. Furthermore, since hospitals are usually the primary healthcare facilities in the majority of countries, more screenings are carried out there, which suggests that demand and adoption have increased.
Capsule Endoscopy Market- Geographical Insights
In 2024, North America held a dominant position in the global market for Capsule Endoscopy because of the growing demand for less invasive screening methods and the uptake of technologically advanced systems and goods. Another element driving the market's expansion is the region's enhanced healthcare infrastructure. Furthermore, one of the main drivers of market expansion in the area is growing awareness of the importance of early illness screening for problems like cancer, gastrointestinal disorders, and other chronic conditions.
However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR because endoscopic technologies that use capsules are becoming more and more popular for screening procedures. The region will also flourish as a result of the expanding older population and better healthcare facilities. One of the main reasons the region has attracted foreign investors is its notable economic progress. The market is expanding due to the existence of significant competitors and the dynamic start-up environment.
The market is highly competitive because of the increasing need for endoscopic systems and capsule-based endoscopes for a range of screening and diagnostic operations. Furthermore, major firms' technological developments in the endoscopy area are intensifying rivalry. Additionally, some of the measures being done by major competitors such as MEDTRONIC PLC., Shangxian Minimal Invassive Inc., IntroMedic Co., Fujifilm Holding Corporation, Olympus Corporation, and others to boost their market positions include expanding research and development in the field of capsule-based endoscopic technologies, forming strategic alliances with other market participants through mergers and acquisitions, product launches, and collaborations, and more. For instance, Medtronic introduced GI Genius, a colorectal cancer endoscopic module, in India in August 2022. By providing real-time data utilizing artificial intelligence (AI) and enhanced visualization during colonoscopy, the device enables physicians to detect and treat colorectal cancer.
Recent Development
November 2021: The FDA approved Medtronic plc's PillCam device for remote endoscopic procedures. The goal of the PillCam SB3 program is to give clients quick and precise results from the convenience of their homes by fusing Amazon logistics with the company's PillCam technologies.